Lpl Financial LLC Geron Corp Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Geron Corp stock. As of the latest transaction made, Lpl Financial LLC holds 284,058 shares of GERN stock, worth $991,362. This represents 0.0% of its overall portfolio holdings.

Number of Shares

284,058

Previous 250,327 13.47%

Holding current value

$991,362

Previous $1.06 Million 21.49%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$4.17 - $4.99 $140,658 - $168,317	33,731 Added 13.47%	284,058 $1.29 Million
Q2 2024 Aug 07, 2024	BUY	$3.1 - $5.09 $169,154 - $277,740	54,566 Added 27.87%	250,327 $1.06 Million
Q1 2024 May 10, 2024	BUY	$1.75 - $3.44 $129,850 - $255,248	74,200 Added 61.04%	195,761 $646,000
Q4 2023 Feb 14, 2024	BUY	$1.74 - $2.31 $27,177 - $36,079	15,619 Added 14.74%	121,561 $256,000
Q3 2023 Nov 13, 2023	BUY	$2.11 - $3.28 $15,983 - $24,846	7,575 Added 7.7%	105,942 $224,000
Q2 2023 Jul 31, 2023	SELL	$1.97 - $3.69 $37,036 - $69,372	-18,800 Reduced 16.05%	98,367 $315,000
Q1 2023 May 10, 2023	SELL	$2.14 - $3.4 $5,136 - $8,160	-2,400 Reduced 2.01%	117,167 $254,000
Q3 2022 Nov 14, 2022	BUY	$1.67 - $2.94 $29,141 - $51,303	17,450 Added 17.09%	119,567 $280,000
Q2 2022 Aug 12, 2022	SELL	$1.19 - $1.65 $68,549 - $95,048	-57,605 Reduced 36.07%	102,117 $158,000
Q1 2022 May 16, 2022	BUY	$0.99 - $1.6 $2,349 - $3,796	2,373 Added 1.51%	159,722 $217,000
Q4 2021 Feb 14, 2022	BUY	$1.22 - $1.72 $2,257 - $3,182	1,850 Added 1.19%	157,349 $192,000
Q3 2021 Nov 15, 2021	BUY	$1.2 - $1.5 $560 - $700	467 Added 0.3%	155,499 $213,000
Q2 2021 Aug 13, 2021	BUY	$1.25 - $1.83 $77,603 - $113,611	62,083 Added 66.79%	155,032 $219,000
Q1 2021 May 14, 2021	BUY	$1.52 - $2.1 $118,000 - $163,027	77,632 Added 506.84%	92,949 $147,000
Q4 2020 Feb 12, 2021	SELL	$1.55 - $2.05 $1,550 - $2,050	-1,000 Reduced 6.13%	15,317 $24,000
Q3 2020 Nov 09, 2020	BUY	$1.59 - $2.19 $1,272 - $1,752	800 Added 5.16%	16,317 $28,000
Q2 2020 Aug 13, 2020	SELL	$1.05 - $2.18 $735 - $1,526	-700 Reduced 4.32%	15,517 $34,000
Q1 2020 May 14, 2020	BUY	$0.89 - $1.49 $267 - $447	300 Added 1.88%	16,217 $19,000
Q4 2019 Feb 14, 2020	SELL	$1.27 - $1.54 $762 - $924	-600 Reduced 3.63%	15,917 $22,000
Q2 2019 Aug 09, 2019	SELL	$1.37 - $2.02 $2,945 - $4,343	-2,150 Reduced 11.52%	16,517 $23,000
Q1 2019 May 08, 2019	BUY	$1.01 - $1.83 $505 - $915	500 Added 2.75%	18,667 $31,000
Q4 2018 Feb 07, 2019	SELL	$0.98 - $1.85 $9,506 - $17,945	-9,700 Reduced 34.81%	18,167 $18,000
Q3 2018 Nov 14, 2018	BUY	$1.76 - $6.38 $440 - $1,595	250 Added 0.91%	27,867 $49,000
Q2 2018 Aug 14, 2018	BUY	$3.29 - $4.82 $10,528 - $15,424	3,200 Added 13.11%	27,617 $95,000
Q1 2018 May 15, 2018	BUY	$1.81 - $5.98 $16,863 - $55,715	9,317 Added 61.7%	24,417 $104,000
Q4 2017 Feb 14, 2018	SELL	$1.8 - $2.32 $5,400 - $6,959	-3,000 Reduced 16.57%	15,100 $27,000
Q3 2017 Nov 14, 2017	SELL	$1.99 - $2.65 $497 - $662	-250 Reduced 1.36%	18,100 $39,000
Q2 2017 Aug 14, 2017	BUY	N/A	18,350	18,350 $51,000

Others Institutions Holding GERN

# of Institutions

274

Shares Held

491M

Call Options Held

1.87M

Put Options Held

690K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.32B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Geron Corp Transaction History